Primary tabs

Other Access

The information on this page (the dataset metadata) is also available in these formats.

JSON RDF

via the DKAN API

Dose-finding of a fixed dose XM22 in patients with breast cancer receiving 4 cycles of chemotherapy versus 6 mg Neulasta

The primary objective of this study is dose-finding of a fixed dose of XM22 compared to 6 mg Neulasta in patients with breast cancer receiving chemotherapy CTX

Data and Resources

FieldValue
Modified
2019-04-21
Release Date
2018-05-03
Identifier
034961f8-7437-40ca-8134-aa7ed67ed1f1
License
Public Access Level
Public